These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7653976)

  • 1. A study of platelet alloantibody in multiply-transfused haematology patients.
    Linn YC; Prakash P; Ong YW
    Ann Acad Med Singap; 1995 Mar; 24(2):305-11. PubMed ID: 7653976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
    Barz D; Gatzka E; Kollmorgen I
    Beitr Infusionsther Transfusionsmed; 1996; 33():47-54. PubMed ID: 8974708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study.
    Novotny VM; van Doorn R; Witvliet MD; Claas FH; Brand A
    Blood; 1995 Apr; 85(7):1736-41. PubMed ID: 7703481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretic and practical aspects of platelet crossmatching.
    von dem Borne AE; Ouwehand WH; Kuijpers RW
    Transfus Med Rev; 1990 Oct; 4(4):265-78. PubMed ID: 2134633
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet-specific antibodies in transfused patients.
    Uhrynowska M; Zupańska B
    Eur J Haematol; 1996 Apr; 56(4):248-51. PubMed ID: 8641394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
    Kuntz BM; Wollenhaupt HJ; Brüster HT
    Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological screening, using three different test systems of platelet-transfused patients with hematologic-oncologic disorders.
    Wernet D; Schnaidt M; Mayer G; Northoff H
    Vox Sang; 1993; 65(2):108-13. PubMed ID: 8212664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transfusion purpura caused by anti-HPA-3a antibodies that are only detectable using whole platelets in the platelet immunofluorescence test.
    Barba P; Pallarés P; Nogués N; Canals C; Gracia M; Vinyets I; Muñiz-Diaz E
    Transfus Med; 2010 Jun; 20(3):200-2. PubMed ID: 19919615
    [No Abstract]   [Full Text] [Related]  

  • 10. Flow cytometric detection of platelet-reactive antibodies and application in platelet crossmatching.
    Köhler M; Dittmann J; Legler TJ; Lynen R; Humpe A; Riggert J; Neumeyer H; Pies A; Panzer S; Mayr WR
    Transfusion; 1996 Mar; 36(3):250-5. PubMed ID: 8604511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet antibody screening by flow cytometry is more sensitive than solid phase red cell adherence assay and lymphocytotoxicity technique: a comparative study in Thai patients.
    Buakaew J; Promwong C
    Asian Pac J Allergy Immunol; 2010; 28(2-3):177-84. PubMed ID: 21038788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
    Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
    Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of solid phase red cell adherence assay for the detection of platelet antibodies in patients with thrombocytopenia.
    Vongchan P; Nawarawong W; Linhardt RJ
    Am J Clin Pathol; 2008 Sep; 130(3):455-66. PubMed ID: 18701420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases.
    Pai SC; Lo SC; Lin Tsai SJ; Chang JS; Lin DT; Lin KS; Lin LI
    Transfusion; 2010 Nov; 50(11):2318-27. PubMed ID: 20497513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of anti-platelet antibody].
    Tsubaki K
    Rinsho Ketsueki; 1990 Jun; 31(6):713-9. PubMed ID: 2214162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody formation after filtered blood cell replacement in hematologic-oncologic patients].
    Barz D; Staack D; Lehmann R; Stange K; Schnurstein K
    Beitr Infusionsther Transfusionsmed; 1996; 33():30-4. PubMed ID: 8974705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cells, HLA and platelet antibody formation in patients with multiple transfusions.
    Chow MP; Hu HY; Lyou JY; Lin JS; Yung CH; Lee A; Lee TD
    Acta Haematol; 1994; 92(2):57-60. PubMed ID: 7817704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet crossmatching with lymphocytotoxicity test: an effective method in alloimmunized Chinese patients.
    Chow MP; Yung CH; Hu HY; Tzeng JL; Lin WM; Lin CK
    Transfusion; 1991 Sep; 31(7):595-9. PubMed ID: 1891789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.